Victoria M Knepp

Title: Victoria M Knepp: Innovator in Nerve Growth Factor Formulations

Introduction

Victoria M Knepp is a prominent inventor based in Sunnyvale, CA (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the area of nerve growth factor. With a total of 2 patents, her work focuses on developing stable formulations that can aid in the treatment of neurological disorders.

Latest Patents

Knepp's latest patents include innovative formulations of nerve growth factor. The first patent details stable aqueous formulations of nerve growth factor suitable for lyophilization and subsequent reconstitution. This formulation involves admixing nerve growth factor with sugars and buffers. The second patent presents pharmaceutical formulations of human nerve growth factor in isotonic solutions, buffered to maintain a pH between 4.5 and 6.0. These formulations may also contain carriers such as human serum albumin. Both patents are particularly useful for treating Alzheimer's disease and other neuronal disorders.

Career Highlights

Victoria M Knepp is associated with Syntex (U.S.A.) Inc., where she has been instrumental in advancing research and development in her field. Her expertise in nerve growth factor formulations has positioned her as a key player in the pharmaceutical industry.

Collaborations

Knepp has collaborated with notable colleagues, including Deborah M Lidgate and Richard Maskiewicz. These partnerships have contributed to the success of her research and the development of her patented formulations.

Conclusion

Victoria M Knepp's innovative work in nerve growth factor formulations showcases her dedication to advancing medical science. Her contributions are vital for developing treatments for neurological disorders, making her a significant figure in the field of pharmaceuticals.